Purdue Pharma patents expiration
1. Intermezzo patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7682628 | PURDUE PHARMA | Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof |
Feb, 2025
(1 year, 4 months from now) | |
| US8252809 | PURDUE PHARMA | Compositions for treating insomnia |
Feb, 2025
(1 year, 4 months from now) | |
| US7658945 | PURDUE PHARMA | Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof |
Apr, 2027
(3 years from now) | |
| US8242131 | PURDUE PHARMA | Methods of treating middle-of-the-night insomnia |
Aug, 2029
(5 years from now) | |
Drugs and Companies using ZOLPIDEM TARTRATE ingredient
Market Authorisation Date: 23 November, 2011
Treatment: Method for treating insomnia; Method of treating middle-of-the-night insomnia
Dosage: TABLET;SUBLINGUAL
How can I launch a generic of INTERMEZZO before it's drug patent expiration?
More Information on Dosage
INTERMEZZO family patents
2. Ryzolt patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7988998 | PURDUE PHARMA | Sustained-release tramadol formulations with 24-hour efficacy |
Oct, 2023
(23 days from now) | |
Drugs and Companies using TRAMADOL HYDROCHLORIDE ingredient
Market Authorisation Date: 30 December, 2008
Treatment: NA
Dosage: TABLET, EXTENDED RELEASE;ORAL
How can I launch a generic of RYZOLT before it's drug patent expiration?
More Information on Dosage
RYZOLT family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic